Literature DB >> 7808212

ROC curves and the areas under them for dichotomized tests: empirical findings for logistically and normally distributed diagnostic test results.

Y T van der Schouw1, H Straatman, A L Verbeek.   

Abstract

Many measures, including sensitivity and specificity, predictive values, and likelihood ratios, are available for the assessment of diagnostic tests. A drawback of the use of these measures is that continuous test results are often dichotomized, with consequent loss of information. Receiver operating characteristic (ROC) curves do not depend on discrimination thresholds, and therefore the area under the ROC curve (AUC) is one of the preferred measures. Although quantitative test results are often presented dichotomized, it would be convenient still to be able to estimate the ROC curve and the AUC. The authors present equations for such estimates when only one pair of a true- and a false-positive rate is given, for inherently logistically and normally distributed data. Illustrative empirical data are provided for both distributions. In contradiction to earlier reports, the authors also show that differential disease verification may skew the ROC curve. The ROC curve is thus not invariant to selection bias.

Mesh:

Substances:

Year:  1994        PMID: 7808212     DOI: 10.1177/0272989X9401400408

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  4 in total

Review 1.  Evaluation of commercially available Helicobacter pylori serology kits: a review.

Authors:  R J Laheij; H Straatman; J B Jansen; A L Verbeek
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

2.  Resection of residual retroperitoneal masses in testicular cancer: evaluation and improvement of selection criteria. The ReHiT study group. Re-analysis of histology in testicular cancer.

Authors:  E W Steyerberg; H J Keizer; S D Fosså; D T Sleijfer; D F Bajorin; J P Donohue; J D Habbema
Journal:  Br J Cancer       Date:  1996-11       Impact factor: 7.640

3.  Graphene-modified CePO4 nanorods effectively treat breast cancer-induced bone metastases and regulate macrophage polarization to improve osteo-inductive ability.

Authors:  Yu-Wei Ge; Xiao-Liang Liu; De-Gang Yu; Zhen-An Zhu; Qin-Fei Ke; Yuan-Qing Mao; Ya-Ping Guo; Jing-Wei Zhang
Journal:  J Nanobiotechnology       Date:  2021-01-07       Impact factor: 10.435

4.  Predicting technique survival in peritoneal dialysis patients: comparing artificial neural networks and logistic regression.

Authors:  Navdeep Tangri; David Ansell; David Naimark
Journal:  Nephrol Dial Transplant       Date:  2008-04-25       Impact factor: 5.992

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.